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Objectives. We sought o characterize myocardial echodensity 
in asymptomatic patients with insulin-dependent diabetes and 
normal conventional two-dimensional echocardiographic findings 
to determine whether ultrasound tissue characterization can 
detect ultrastructural changes in myocardium, such as an in- 
crease in collagen content. 
Background. Fibrosis alters the acoustic properties of the heart 
in animals and humans, and these changes are detectable by 
cardiac tissue characterization with ultrasound. Early changes 
detected in the diabetic heart include increased interstitial colla- 
gen deposition. 
Methods. Using two-dimensional echocardiography, we evalu- 
ated 26 asymptomatic patients with insulin-dependent diabetes 
with normal regional and global rest function, and 17 age- and 
gender-matched control subjects. By selection, all diabetic pa- 
tients were normotensive and had negative maximal exercise 
stress test results to avoid the confounding effects of hypertension 
and coronary artery disease. Using an echocardiographic instru- 
ment implemented at the Institute of Clinical Physiology, we 
performed an on-line radiofrequency analysis to obtain quantita- 
tive operator-independent measurements of the integrated back- 
scatter signal of the ventricular septum and posterior wall. The 
integrated values of the radiofrequency signal from the myocar- 
dial wall were normalized for those from the pericardial interface 
and were expressed as percentages (integrated backscatter index). 
Results. Diabetic patients showed a significant increase in 
myocardial echodensity both in the septum ([mean + SD] 36.6 -+ 
8.1 vs. 23.6 _+ 4.4, p < 0.0001) and posterior wall (21.2 +- 5.3 vs. 
18.4 -+ 3.7, p < 0.001). By individual patient analysis, 17 patients 
exceeded the 95% confidence limits for normal myocardial echo- 
cardiographic reflectivity found in normal subjects, and only 3 
had a relatively abnormal transmitral Doppler filling pattern (E/A 
ratio), mainly consisting of an abnormally increased late peak 
flow velocity (65% vs. 11%, p < 0.001). The increased myocardial 
intensity was similar in patients with (n = 16) and without (n = 
10) noncardiac omplications, such as retinopathy or nephropa- 
thy (37.5 -+ 7.9% vs. 35.0 -+ 8.3%, p = 0.35). 
Conclusions. Abnormally increased myocardial echodensity, 
possibly related to collagen deposition, can be detected in asymp- 
tomatic diabetic patients with normal rest function. Theoretically, 
this finding might be considered a very early preclinical alteration 
potentially related to subsequent development of diabetic car- 
diomyopathy. 
(J Am Coil Cardiol 1995;25:1408-15) 
Ultrasound tissue characterization s atechnique now available 
for clinical studies that can identify and characterize abnor- 
malities in the physical or physiologic state of biologic struc- 
tures on the basis of analyzing the interactions between 
ultrasound and tissue (1-4). In particular, ultrasound tissue 
characterization with backscatter analysis in the radio- 
frequency domain provides a particularly robust, but techni- 
cally demanding, method of quantitatively assessing the acous- 
tic properties of myocardium. Two main variables can be 
derived from backscatter analysis: 1) indexes for measuring 
cyclic (systolic to diastolic) variation that are mainly linked to 
intramural function and contractility, albeit in a complex, only 
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partially understood manner (1-4), and 2) indexes for measur- 
ing the absolute chodensity value that are mainly linked to the 
structural, histologic omponent ofthe myocardial tissue, such 
as collagen content (1-4). This technique has been applied in 
several myocardial diseases and shows potential for preclinical 
detection of myocardial involvement, even at a stage when 
conventional echocardiographic indexes are within the normal 
range. This early involvement has been documented by ultra- 
sound tissue characterization in a variety of pathologic ondi- 
tions, including cardiac hemochromatosis (5),myocardial isch- 
emia (6) and acute cardiac rejection (7,8). In the diabetic 
human heart, Perez et al. (9) have documented a blunted cyclic 
backscatter variation in the absence of changes in echocardio- 
graphically assessed structure and function. The behavior of 
absolute chodensity in the myocardial wall of diabetic heart 
remains unknown. The hypothesis underlying the present study 
is that a change in myocardial structure may occur in the early 
stage of the diabetic disease in the absence of any clinical sign 
of cardiac involvement (10). Experimental (11-13) and human 
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Table 1. Demographic Features, Hemodynamic Factors and Metabolic Patterns 
Group A Group B p Value 
Age (yr) 32.6 -+ 10.0 32.6 _+ 9.9 0.48 
Gender (M/F) 10/16 7/10 
Height (cm) 166.5 - 7.4 168.8 -+ 9.5 0.23 
Weight (kg) 62.7 _+ 8.5 63.7 + 10.7 0.65 
Body surface (m 2) 1.72 + 0.1 1.72 ± 0.2 0.50 
SAP (ram Hg) 123.4 _+ 12.7 119.7 ± 10.4 0.17 
DAP (mm Hg) 75.6 -+ 7.5 75.0 _+ 6.1 0.93 
MAP (mm Hg) 91.5 +_ 8.7 89.9 ± 6.7 0.85 
Heart rate (/rain) 75.6 + 10.1 79.6 -+ 9.5 0.78 
Serum cholesterol (mmol/liter) 4.72 z 1.10 5.17 ± 1.14 0.67 
HDL cholesterol (retool/liter) 1.15 _+ 0.21 1.19 _+ 0.9 0.79 
J'riglycerides (mmol/liter) 1.00 _+ 0.35 1.09 ± 0.64 0.34 
Lipoprotein (a) (mg/dl) 17.4 _+ 21.8 12.2 +_ 14.8 0.54 
Apolipoprotein AI (mg/dl) 151.7 _+ 25.7 150.6 ± 23.2 0.28 
Apolipoprotein A2 (mg/dl) 87.4 ± 24.4 93.2 + 19.6 0.56 
HbAlc (%) 8.3 ± 1.5 
Serum urea (retool/liter) 12.8 +_ 3.5 13.3 +_ 6.4 0.83 
Serum creatinine 0xmol/liter) 80.9 2 12.9 89.3 + 10.1 0.56 
Serum glucose (mmol/liter) 12.2 + 5.6 4.8 _+ 0.6 < 0.0001 
Urea clearance (ml/min) 41.5 + 12.7 39.2 ± 10.9 0.73 
Creatinine clearance (ml/min) 89.3 ± 26.4 90.6 ± 16.3 0.18 
Urine glucose (retool/24 h) 53.6 ± 69.8 0.35 ± 0.2 < 0.001 
Serum albumin (g/liter) 44.8 ± 5.1 47.3 + 6.0 0.23 
Urine albumin (rag/24 h) 33.3 ± 44.1 28.3 + 35.9 0.31 
Data presented are mean value ± SD or number of patients or subjects. DAP -- diastolic arterial pressure; F = 
female; Group A = diabetic patients; Group B = normal control subjects; HbAlc = glycosylated hemoglobin; HDL - 
high density, lipoprotein; M - male; MAP = mean arterial pressure; SAP systolic arterial pressure. 
pathologic (14) evidence behind this hypothesis documents 
that diabetic hearts without significant coronary lesions show 
collagen accumulation i perivascular loci, between myofibers 
or as replacement fibrosis (10). The collagen accumulation is 
linearly related to ultrasound backscatter, as shown concor- 
dantly by experimental (1-4,15) and clinical (16,17) studies. 
In the present study, we sought o assess in vivo myocardial 
tissue echoreflectivity in diabetic human hearts and to corre- 
late this finding with clinical, metabolic, two-dimensional nd 
Doppler echocardiographic data. 
Methods 
Study patients. Twenty-six patients with type I diabetes 
were recruited from the Diabetes Unit of the Second Medical 
Clinic of Pisa University. By selection all patients were asymp- 
tomatic, with normal findings on physical examination, ega- 
tive maximal exercise stress test results and a technically good 
baseline echocardiographic study. A control group of 17 
normal subjects was also evaluated. The two groups were 
comparable in age, weight and body surface. No subject had 
pathologic systolic and diastolic arterial pressures, defined 
according to World Health Organization criteria (18). A 
representative alue of arterial blood pressure was measured 
by cuff sphygmomanometer at echocardiographic study. Mean 
arterial pressure (MAP) was calculated as follows: MAP = 
DAP + 1/3(SAP - DAP), where DAP (SAP) = diastolic 
(systolic) arterial pressure. The demographic features of the 
two groups are reported in Table 1. Exclusion criteria were the 
documentation of valvular heart disease by Doppler analysis, 
ventricular dyssynergies of contraction and patients who 
smoked >5 cigarettes/day. 
Evaluation of metabolic and clinical variables. Serum cho- 
lesterol, triglyceride, urea, creatinine and glucose levels 
were determined with a BM/Hitachi System 717 model 
(Hitachi Ltd., Tokyo, Japan) and reagents from Boehringer 
Mannheim. Glycosylated hemoglobin was evaluated by the 
Biorad DIAMAT fully automated glycosylated hemoglobin 
Analyzer System. Urine urea, creatinine and glucose were 
assayed using a Synchron Cx3 (Beckman Instruments Inc.) 
automated analyzer. High density lipoprotein (HDL) choles- 
terol was measured after precipitation of other lipoproteins 
with phosphotungstic a id and reagents from Menarini (Flor- 
ence, Italy). Lipoprotein (a) was measured with a commercial 
enzyme-linked immunosorbent assay [Immunoenzyme Lp (a)] 
(Immuno Division Diagnostic, Pisa, Italy). Apolipoproteins A1 
and B were determined by the kinetic immunonephelometric 
method with an automated instrument (Bering Institute neph- 
elometer and reagents). Serum and urine albumin were also 
determined by the immunonephelometric method. All diabetic 
subjects were taking insulin therapy (mean daily insulin dose 
0.78 + 0.12 IU/kg) (19). On the day before the examination, 
subjects collected a 24-h urine specimen to be analyzed for 
urinary albumin, creatinine, urea and glucose. After an over- 
Figure 1. Top, Two-dimensional image showing left ventricular long-axis 
view, with the sample volume positioned on the septum strictly perpendicular 
to the ultrasound beam in a control subject. Bottom, Relative backscattered 
radioffequency signal corresponding to the septal area. 
Figure 2. Top, Two-dimensional image showing left ventricular long-axis 
view, with the sample volume positioned on the septum strictly perpendicular 
to the ultrasound beam, in a diabetic patient. Bottom, Relative backscattered 
radioffequency signal corresponding to the septal area. 
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night fast, venous blood was drawn for plasma glucose, creat- 
inine, urea, glycosylated hemoglobin, total and HDL choles- 
terol and triglyceride analysis. All of these metabolic variables 
were analyzed in the same manner in the control group. 
The tests used to evaluate autonomic neuropathy were the 
following: heart rate variability on six maximal breaths per rain, 
heart rate increase on standing at 15 s, Valsalva ratio and 
postural systolic blood pressure decrease on standing (20). 
Conventional Doppler echocardiography. M-mode and 
two-dimensional echocardiograms with Doppler analysis were 
obtained for all subjects by means of a commercially available 
machine (Hewlett-Packard Sonos 1000 with 2.5- or 3.5-MHz 
transducer). During the echocardiographic examination, all 
subjects were in the semisupine l ft lateral decubitus position. 
Two-dimensional images were obtained in the parasternal 
long- and short-axis views and in the apical four- and two- 
chamber views by using standard transducer positions. The 
following variables were measured from the M-mode echocar- 
diographic tracings guided by two-dimensional imaging: 
1) end-diastolic diameter (cm); 2) end-diastolic diameter in- 
dex, as end-diastolic diameter/body surface ratio (cm/m2); 3) 
percent fractional shortening of the left ventricle (%); 4) septal 
and posterior wall thickness at end-diastole (cm); and 5) left 
ventricular mass (g) by American Society of Echocardiography 
formula and left ventricular mass index (g/m 2) (left ventricular 
mass/body surface ratio) (21). 
Pulsed Doppler transmitral flow velocity profile was ob- 
tained from the apical four-chamber view, and the sample 
volume was positioned just below the mitral valve leaflets. The 
following variables were evaluated: 1) peak E (peak trans- 
mitral flow velocity in early diastole); 2) peak A (peak trans- 
mitral flow velocity in late diastole); 3) E/A ratio; 4) mitral 
acceleration time (from baseline to peak E wave), corrected 
for heart rate; 5) mitral deceleration time (from peak E wave 
to baseline), corrected for heart rate, and 6) isovolumetric 
relaxation time (by placing the sample volume at an interme- 
diate point between the mitral and aortic valves, it was 
measured as the interval from the end of the left ventricular 
outflow velocity to the onset of mitral inflow), corrected 
for heart rate. Measurements were derived from the average 
of at least five consecutive cardiac cycles. Mitral accelera- 
tion and deceleration times and isovolumetric relaxation 
time were corrected for heart rate by Bazett's formula 
(tlme/,,RRlnterval). 
Ultrasound tissue characterization. An OTE Biomedica 
AU 530 two-dimensional mechanical sector scanner echocar- 
diograph was used for spatial orientation of the ultrasound 
beam; quantitative analysis of ultrasound reflectivity was per- 
formed in the regions of interest, hat is, the ventricular septum 
and the posterior left ventricular f ee wall. These regions were 
visualized from the parasternal long-axis view. The backscat- 
tered signal was acquired at end-diastole because a systematic 
variation in backscatter amplitude occurs during the cardiac 
cycle (1,2). 
A 3.5-MHz frequency transducer was used (focal distance 
7 cm, -3 dB, focal region 6 cm). The transducer bandwidth, 
measured at -3 dB with respect to the 3.5-MHz central 
frequency, was 700 kHz. The "native" (raw) radiofrequency 
signal was sampled before the processing chain of the two- 
dimensional instrument. Briefly, the radiofrequency signal 
undergoes preamplification, bypassing the receiving circuits of 
the ultrasound equipment• The analog signal is fed to an 
amplifier, and the gain sweep of the amplifier (from 2 to 60 riB) 
is accomplished in 30 steps. Such operation allows full use of 
the input dynamic range of the analog to digital converter. 
Sampling is performed by a flash converter with 8 bits of 
amplitude resolution, at a rate of 40 MHz. The digitized signal, 
from analog to digital converter, is analyzed in real time by a 
hardware prototype developed in our electronics laboratory. 
The acquisition of the two-dimensional gate is visualized on 
the two-dimensional image to ensure its proper positioning 
perpendicular on the selected beam (Fig. 1 and 2). For analysis 
of the myocardium, the gate width was kept at 3 /xs, which 
corresponds to 2.35 mm (for 128 points), given the velocity of 
ultrasound in biologic tissues of 1.57 mm//zs. This allowed 
sampling on the radiofrequency signal in the middle layers of 
the myocardium, thus excluding epicardial and endocardial 
specular reflections. The acquisition gate was kept immediately 
behind the specular echo of the endocardium (left endocar- 
dium for the septum) to minimize the transmural variations in 
backscatter, which are influenced by the position from which 
the signal is acquired within the wall (Figs. 1 and 2). The 
representative alue for the ventricular septum and posterior 
free wall was calculated as the average of three values. For 
evaluation of the pericardial echo, we used a 1.5-/xs gate length 
(which corresponds to 1.2 ram, for -64 points) (4). The 
acquisition gate was centered on the strongest pericardial 
reflections, just behind the mitral leaflets. The representative 
value for the pericardial echo was calculated as the mean of 
three values (mean variability 4.5%). Hardware analysis in- 
volved measurement of the integrated amplitude of the recti- 
fied radiofrequency signal corresponding to the two- 
dimensional area selected from the echocardiographic image. 
The system provided a simultaneous display of conventional 
information together with tissue characterization variables (the 
two-dimensional integrated backscatter alphanumeric index 
and the lateral displacement profile averaged over the selected 
depth). Alphanumeric two-dimensional integrated backscatter 
data values were transferred on-line to a personal computer 
(model AT) for statistical analysis. The reproducibility of the 
method was good: In our laboratories the coefficient of corre- 
lation for intraobserver measurements was r = 0.92; that for 
interobserver measurements r = 0.88. 
Ultrasound quantitative data analysis. Primary, not nor- 
malized or compensated, two-dimensional integrated backscat- 
ter values were not considered for analysis because they are 
highly influenced by chest morphology, heart structure depth 
and ultrasound impedance, which differ patient by patient. 
Therefore, to assess quantitatively the reflectivity of the ven- 
tricular septum and posterior free wall, we used the percent 
two-dimensional integrated backscatter, expressed as a corn- 
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Table 2. Conventional and Doppler Echocardiographic Variables 
Group A Group B p Value 
EDD (cm) 4.43 _+ 0.4 4.50 : 0.3 0.23 
EDD i (cm/m 2) 2.57 + 0.3 2.6 - 0.19 0.34 
FS (%) 40.1 +_ 4.6 38.7 + 3.8 0.51 
STh (cm) 0.94 + 0.09 0.96 ± 0.06 0.25 
PWTh (cm) 0.95 + 0.09 0.95 _+ 0.08 0.51 
LVM (g) 169.1 + 46.2 169.0 _+ 34.2 0.9 
LVM i (g/m 2) 97.3 _+ 20.9 97.5 + 12.7 0.75 
Peak E (m/s) 0.88 _+ 0.2 0.86 + 0.1 (I.34 
Peak A (m/s) 0.69 ± 0.1 0.58 + 0.1 < 0.01 
E/A ratio 1.30 - 0.3 1.55 ± 0.33 < 0.01 
MATc 2.6 + (I.5 2.6 ± 0.5 0.28 
MDTc 4.8 -+ 0.9 5.1 + 0.7 0.23 
IVRTc 3.5 +- 0.8 3.6 + {).3 0.42 
Data presented are mean values + SD. EDD - end-diastolic diameter; 
EDD~ - end-diastolic diameter index; FS percent fractional shortening of left 
ventricle; Group A = diabetic subjects; Group B = normal control subjects; 
IVRTc corrected isovolumetric relaxation time; LVM - left ventricular mass; 
LVM~ - left ventricular mass index; MATc - corrected mitral acceleration time; 
MDTc = corrected mitral deceleration time; Peak A peak transmittal flow 
velocity in late diastole; Peak E = peak transmitral flow velocity in early diastole; 
PWTh = posterior wall thickness at end-diastole; STh - septal wall thickness at 
end-diastole. 
parison with the pericardial interface. To obtain quantitative 
assessment of the reflectivity of the ventricular septum and 
posterior free wall, we used the percent wo-dimensional 
integrated backscatter, expressed as a comparison with the 
pericardial interface. Two-dimensional integrated backscatter 
results for each heart structure, initially displayed in mV, were 
then expressed in percent values, assigning 100% to the 
pericardial interface (from which the maximal echointensity 
was consistently recorded in the individual patients). The 
individual pericardial signal strength was used to normalize 
myocardial signals in each patient. 
Statistical analysis. Continuous variables were expressed 
as mean value + 1 SD. Differences were tested for significance 
by paired and unpaired Student t tests. Upper and lower 95% 
confidence limits for each variable were calculated from the 
two tails of the Student t test distribution using the following 
formulas: mean value _+ (2.042 × SD) and mean - (2.042 × 
SD), respectively. Relations between radiofrequency and two- 
dimensional echocardiographic measurements were expressed 
in terms of linear regression analysis; chi-square analysis was 
used to compare categorical variables; p < 0.05 was considered 
significant. 
Resu l ts  
Clinical, hemodynamic and metabolic data from the dia- 
betic patients and normal control subjects are reported in 
Table 1. The two groups were similar for heart rate and blood 
pressure values, as well as for metabolic variables except for 
serum and urine glucose. Of the 26 type I diabetic patients, 10 
had uncomplicated courses (mean diabetes duration 5.2 _+ 2.5 
years). Sixteen subjects (mean diabetes duration 17.2 _+ 5.6 
Table 3. Ul t rasound Quant i tat ive Data 
Integrated 
Backscatter Index Group A Group B p Value 
Septum (%) 36.6 + 8.1 23.6 _+ 4.4 < 0.0001 
Posterior wall (%) 21.2 -+ 5.3 18.4 : 3.7 < 0.001 
Pericardium 103.9 -+ 19.8 109.8 + 5.6 0.173 
Data presented are mean value + SD. Group A = diabetic subjects; Group 
B = normal control subjects. 
years) had noncardiac omplications, consisting of retinop- 
athy in 15 (background or proliferative retinopathy alone ir~ 
normoalbuminuric normotensive diabetic patients) wit~ 
or without "incipient nephropathy" in 7 (persistent micro-. 
albuminuria, urinary albumin excretion rate [22] >20 bw: 
<200 ~g/min in diabetic patients with concomitant retinopathy 
but without any other renal or urinary tract disease). No 
diabetic patient had clinical or laboratory findings of auto.- 
nomic neuropathy. 
Technically satisfactory conventional echocardiographic 
images and radiofrequency ultrasound signals were obtained 
for each subject. 
M-mode echocardiographic findings. M-mode echocardio- 
graphic measurements were similar in diabetic patients and 
control subjects and are reported in Table 2. 
Doppler transmitral flow findings. Of the Doppler indexes 
evaluating left ventricular diastolic filling, late peak flow 
velocity was significantly higher in diabetic patients (p < 0.01); 
early peak flow velocity (El was similar between the groups. 
The E/A ratio was significantly higher in the control group than 
in diabetic patients (p < 0.01; Table 2). When individual 
patient analysis was performed, the E/A ratio was beyond the 
95% confidence limits, obtained from the normal control 
subjects, in 11%, of the study patients. 
Quantitative analysis of ultrasound backscatter. Table 3 
reports the percent and compensated two-dimensional inte- 
grated backscatter values of the ventricular segments analyzed 
in diabetic patients and in the normal control subjects. The 
integrated backscatter index of the septum and left ventricular 
posterior wall was significantly higher in diabetic patients than 
that in the control group (Fig. 3). Among diabetic patients, no 
significant difference in integrated backscatter index in the 
septum was found between those with (n = 16) and without 
(n = 10) noncardiac complications (37.5 + 7.9% vs. 35.0 _~: 
8.3%, p = 0.35). 
Relation between conventional echocardiographic mea- 
surements and radiofrequency analysis. In diabetic patients, 
no significant correlation was found between regional myocar- 
dial reflectivity (considered as percent integrated backscatter) 
of the septal and posterior walls and the corresponding wall 
thickness (r = -0.31, p = 0.28 and r = -0.09, p = 0.65, 
respectively; Fig. 4). No significant correlation was found 
between the septal percent backscatter value and left ventric- 
ular end-diastolic diameter (  = -0.04, p = NS). 
When individual patient analysis was performed, the septal 
backscatter index was beyond the 95% confidence limits 
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Figure 3. Percent wo-dimensional integrated backscatter o~" 
index (IBI) values of the septum and posterior wall in --- 
patients with diabetes ( olid bars) and in control subjects 
(open bars). Quantitative reflectivity ofthe myocardial walls -- 







Septum Posterior wall 
obtained from the normal group in 17 (65%) of the 26 study 
patients, ignificantly higher in comparison with those selected 
with Doppler analysis (11%; p < 0.001). 
Discuss ion  
Abnormally increased myocardial echodensity--possibly 
related to collagen deposition--can bedetected in asymptom- 
atic diabetic patients with normal rest function and may 
provide a very early and preclinical finding probably related to 
the development of a subsequent clinical "diabetic ardiomy- 
opathy" in these patients. The increased myocardial echoden- 
sity was similar in patients with and without noncardiac 
complications. Septal backscatter measurements yielded 
higher values compared with posterior backscatter measure- 
ments in both control and diabetic subjects. This finding has 
been reported previously and consistently in normal subjects 
(23) and is probably due to the ultrasound beam attenuation 
and to the technical characteristics of the acquisition system 
used. 
Biologic basis of increased myocardial acoustic reflectivity. 
The most likely explanation for the increased myocardial 
acoustic reflectivity of the diabetic heart is an augmentation f 
the connective tissue content of the myocardium. Some theo- 
retic and experimental evidence shows that collagen is a 
primary determinant of echocardiographic s attering in myo- 
cardial tissue and that there is a linear relation between 
collagen deposition and backscatter magnitude (1-4,15). Sev- 
eral clinical studies (16,17) have confirmed agood correlation 
between the amplitude of the echo and histologically or 
biochemically assessed collagen content. 
On the basis of published evidence, the increased reflectiv- 
ity in the walls of the diabetic heart should be paralleled by a 
similar increase in connective tissue deposition. Some obser- 
vations support his hypothesis, derived from experimental, 
autopsy and epidemiologic studies. Some experimental obser- 
vations (24) in rats with induced iabetes howed an increase 
in intercellular and perivascular deposition of connective tis- 
sue. In postmortem examinations, the most frequent his- 
topathologic findings in diabetic subjects with clinical evidence 
of congestive heart failure are a variable degree of interstitial 
and perivascular fibrosis and subendocardial thickening of the 
small coronary arteries (25); in addition, asubgroup of diabetic 
patients without clinical evidence of heart disease demon- 
strates asignificantly arger amount of perivascular connective 
tissue than nondiabetic subjects (26). 
Epidemiologic studies (27) have shown that the incidence 
of congestive heart failure is increased indiabetic patients even 
when factors uch as age, blood pressure, plasma cholesterol, 
weight and coronary artery disease are taken into account. 
Therefore, because of both its increased amount and different 
nature, collagen might be the plausible structural substrate of 
increased echodensity. These same changes did not result in 
substantial lterations in Doppler-derived indexes of left ven- 
tricular filling (28), although a relatively higher late peak 
velocity was observed. There was a large overlap in the two 
groups examined. However, the noninvasive valuation of 
diastolic function poses some methodologic problems. In fact, 
all diastolic time-velocity measurements are strictly dependent 
on hemodynamic factors, such as preload or afterload and 
heart rate. The E/A ratio represents a global indicator of 
diastolic function. In our group of patients without clinical 
evidence of heart disease, this Doppler variable substantially 
overlapped in both study groups. This finding demonstrates he 
poor sensitivity of this Doppler index compared with inte- 
grated backscatter indexes, at least in patients without clinical 
symptoms. 
Comparison with previous studies. Perez et al. (9) were 
the first to address the hypothesis that fibrosis or other 
myopathic changes could affect he acoustic properties of the 
myocardium in diabetic patients, signifying an occult cardio- 
myopathy. They found a reduction i  cyclic variation from the 
myocardial wall of diabetic hearts compared with that in 
control hearts and attributed it to fibrosis or other occult 
cardiomyopathic changes in diabetic patients. They also found 
that these changes were more marked in the presence of 
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Figure 4. Top, Scatter plot showing the lack of correlation between the 
integrated backscatter index (IBI) and the diastolic thickness of the 
interventricular septum. Bottom, Scatter plot showing the lack of 
correlation between the integrated backscaner index and the diastolic 
thickness ofthe posterior wall. 
noncardiac diabetic complications, uch as neuropathy and 
retinopathy. 
Our study differs from the pioneering observations ofPerez 
et al. (9) in many respects, including patient selection and, 
most important, he indexes used for ultrasound tissue char- 
acterization. In patient selection, we excluded those with 
hypertension, which is frequently associated with diabetes but 
may itself cause a variation in ultrasound tissue characteriza- 
tion indexes (29,30). In the study of Perez et al. (9), patients 
with noncardiac complications of diabetes had more frequent 
hypertension, which may itself result in a blunting of the cyclic 
variation. Furthermore, although the overwhelming majority 
of patients in the study of Perez et al. (9) had normal 
conventional echocardiographic findings, this was not an inclu- 
sion criterion as it was in the present study. All of our patients 
had negative xercise stress test results, making the presence of 
concomitant coronary artery disease unlikely. Overall, our 
study patients were more strictly selected and more likely to 
represent the specific effects of diabetes on the heart, rather 
than those of associated iseases, such as hypertension or 
coronary artery disease. 
Finally, and most important, we used a conceptually differ- 
ent approach to tissue characterization. The cyclic variation of 
backscatter used by Perez et al. (9) is related to contractile 
function but in a complex, nonlinear manner. The mechanisms 
of cyclic variation of backscatter are not completely under- 
stood, but they are likely to reflect physiologic rather than 
directly biochemical determinants of myocardium. We used, 
instead, the absolute backscatter amplitude, valuated at end- 
diastole, a variable more closely related to the structural 
histologic omposition of the wall. In particular, the amplitude 
of echodensity is directly and linearly related to the biochem- 
ically or histologically assessed collagen content of tissue 
(15,16). Taken together, the data of Perez et al. (9) and our 
own results emphasize the potential of ultrasound tissue charac- 
terization in detecting subtle physiologic and structural bnor- 
malities at a preclinical stage, when conventional echocardio- 
graphic markers are still in the normal range. 
Increased myocardial echodensity in insulin-dependent di- 
abetic patients possibly represents a preclinical alteration, 
conceivably related to the myocardial collagen content in- 
crease, which does not necessarily indicate an actual disease 
but may be considered an early marker of the histopathologic 
findings of diabetic cardiomyopathy. Furthermore, these aug- 
mented ultrasound backscatter indexes probably predate the 
subclinical alterations in diastolic filling and systolic function, 
previously described by different echniques, uch as systolic 
time intervals, radionuclide ventriculography and Doppler 
echocardiography (31-37). 
Increased myocardial backscatter: a sign of impending 
diabetic cardiomyopathy. A hypothesis for a biologic scenario 
underlying our findings might predict, at the myocardial level, 
a situation similar to "impending" diabetic nephropathy. In the 
diabetic kidney, a widening of the glomerular basement mem- 
brane has been described (22), a clinical nephropathy in the 
absence of any detectable nephropathy, which may be demon- 
strated only after 15 to 20 years of diabetes. Diabetologists 
define "incipient" nephropathy asa clinical condition charac- 
terized by albuminuria that goes clinically undetected by 
current methodologies. The microalbuminuric patient is "nor- 
mal" and normotensive according to classic linical criteria but 
has a very high risk of developing clinical nephropathy. Simi- 
larly, type I insulin-dependent diabetes might have a preclini- 
cal phase during which an occult myocardial "alteration" 
develops (either by microangiopathy or by nonenzymatic gly- 
cation), conceivably due to metabolic disease itself. This may 
lead very early on to inappropriate connective tissue deposi- 
tion, detectable noninvasively only by sophisticated methodol- 
ogy, such as ultrasound backscatter. The predictive power for 
the development of clinical diabetic cardiomyopathy of these 
radiofrequency indexes of cardiac damage must be confirmed. 
Follow-up studies addressing this crucial issue are currently in 
progress. 
Limitations of the study. Some limitations of this study 
should be mentioned. 1) No independent histologic or other 
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direct evidence of myocardial abnormalities was available for 
the study subjects. This problem was unavoidable because 
myocardial biopsies would not have been ethically justified in 
these patients, who were clinically healthy from a cardiovascu- 
lar viewpoint. 2) The analysis of standard indexes, derived from 
two-dimensional nd Doppler echocardiography of global sys- 
tolic and diastolic function, did not permit clear differentiation 
between the study groups. This was more clearly achieved, 
both as group and individual patient analysis, when ultrasound 
tissue characterization indexes were considered. Subtler levels 
of impairment in these patients might have been detected with 
more sophisticated assessment of left ventricular function, 
such as evaluation of contractility using load-independent 
measures. 
We are grateful to Dr. Antonio Caselli for masterful editing of the manuscript. 
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